Life Science Leader Joins CardioCrown to Drive Growth and Innovation in MedTech
CardioCrown is thrilled to announce the appointment of Heraldas Gaspariunas as Chief Operations Officer. Heraldas, a highly skilled strategist and problem-solver, brings over four years of experience in the Life Science industry and a proven record of helping ventures secure critical funding and achieve sustainable growth. His appointment marks a significant step forward for CardioCrown as it continues its mission to innovate in the field of stroke rehabilitation and MedTech.
With a BA in International Business and a diverse career spanning CEO and COO roles, Heraldas has demonstrated exceptional leadership and operational insight. He has successfully raised over £366,000 in grant funding for companies and won multiple entrepreneurial competitions, positioning him as an invaluable asset to any venture. His passion lies in collaborating with innovators and driving meaningful change through strategic partnerships.
Victor Harbari, CEO of CardioCrown, commented on the new appointment: “We’re excited to have Heraldas join CardioCrown as our COO. His passion for problem-solving and innovation aligns perfectly with our mission to bring disruptive technology to stroke rehabilitation. Heraldas’s track record speaks for itself, and I’m confident that his expertise will play a pivotal role in shaping our future and advancing our vision.”
Heraldas commitment to innovation and strategic thinking was shaped by his international experiences during his studies, where he developed a unique perspective on tackling complex problems across diverse cultural landscapes. This background, paired with his life sciences expertise, has made him a respected leader in the field.
Heraldas Gaspariunas, newly appointed COO, shared his excitement for joining the team: “I am thrilled to join CardioCrown and work alongside a team committed to advancing technology for meaningful impact in MedTech. CardioCrown’s vision for stroke rehabilitation aligns closely with my passion for solving complex challenges, and I look forward to contributing to the company’s growth and success.”
With Heraldas on board, CardioCrown gains not only a skilled leader but also a dedicated partner in its mission to redefine stroke rehabilitation. His presence is expected to drive operational excellence and position CardioCrown for greater success in the evolving MedTech landscape.
